Johnson & Johnson recently released its third quarter earnings report. Here are four things for orthopedic leaders to know:
- Sales of medical devices for elective procedures like spine and knee surgery lagged behind other medical device segments, which the company partially attributed to procedural backlogs.
- Johnson & Johnson's U.S. orthopedics sales declined 4.5 percent compared to the same period in 2020.
- Hip device sales grew 2.3 percent globally compared to last year, while knee devices grew 2 percent.
- After introducing 17 medical devices in the first half of 2021, Johnson & Johnson introduced the Inhance Shoulder System in Q3 on Aug. 13.